| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive VP Global Business S | Executive Vice President Glob +3 more
3 companies
Marshall Mohr is Director at PACB and has filed Form 4s across 3 companies. Marshall Mohr's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.0M at current prices.
Historically, Marshall Mohr's trades have earned a below-average insider score of 49/100 across 7 rated trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of -8.4%.
The biggest single holding is VEEV (~$2.0M) as Director.
Marshall Mohr has 102 Form 4 filings on record from January 2015 to September 2026, across 3 companies: Director at Veeva Systems (VEEV), 2022–2026; Director at Pacific Biosciences of California (PACB), 2015–2026; Executive VP Global Business S at Intuitive Surgical (ISRG), 2015–2024.
The 225 reported transactions were 101 option exercises, 44 open-market sales, 35 option or other derivative awards and 34 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 30 sales worth about $184.1M.
The largest open-market sale was 108,790 shares of ISRG at an average $385.08 on February 28, 2024, about $41.9M. Twelve months later ISRG was up 46%.
1 of the 2 sales since April 2023 was made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | ISRG Intuitive Surgical Inc | Executive VP Global Business S | Sale+OE10b5-1 | 108,790 | $385.08 | $41,893,066.00 | -69.4% | +3.7% | +45.8% | |
| Jun 14, 2023 | ISRG Intuitive Surgical Inc | Executive VP Global Business S | Sale+OE | 11,250 | $325.00 | $3,656,250.00 | -31.8% | -6.7% | +30.9% | |
| Feb 13, 2023 | ISRG Intuitive Surgical Inc | Executive VP Global Business S | Sale+OE | 33,249 | $245.61 | $8,166,376.66 | -61.6% | +25.7% | +54.6% | |
| Oct 25, 2021 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 20,475 | $339.20 | $6,945,122.05 | - | -20.8% | -30.8% | |
| Jul 26, 2021 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 6,825 | $963.38 | $6,575,080.79 | - | +6.7% | -32.7% | |
| Apr 26, 2021 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 21,963 | $865.69 | $19,013,222.08 | -72.3% | +11.6% | -15.3% | |
| Feb 11, 2021 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 12,487 | $800.00 | $9,989,602.50 | -59.3% | +1.6% | +6.3% | |
| Jan 29, 2021 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 9,375 | $751.66 | $7,046,857.50 | -99.5% | - | - | |
| Oct 26, 2020 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 6,000 | $715.28 | $4,291,690.20 | -29.0% | - | - | |
| Jul 27, 2020 | ISRG Intuitive Surgical Inc | Executive VP & CFO | Sale+OE | 7,500 | $677.19 | $5,078,930.25 | -33.8% | - | - |